PMID: 15217559Jun 26, 2004Paper

Novel strategies for cancer therapy: the potential of genetically modified T lymphocytes

Current Hematology Reports
Isabelle RivièreRenier J Brentjens

Abstract

The genetic modification of T lymphocytes is an important methodology for investigating T-cell biology and bears great promise as a possible strategy for cancer immunotherapy. Several genetic approaches under evaluation aim to facilitate and increase the recognition of tumor antigens, enhance antitumor activities, and counteract the multiple mechanisms responsible for tumor immune evasion in vivo. T cells can also be engineered in an attempt to control their homing, to increase the safety of adoptive T-cell therapies, and express markers that can be tracked by noninvasive imaging technologies.

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

Discovery Medicine
Leslie E Huye, Gianpietro Dotti
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
Sytse J Piersma
Molecular Therapy : the Journal of the American Society of Gene Therapy
Claudia Rossig, Malcolm K Brenner
© 2022 Meta ULC. All rights reserved